IN8BIO, INC. Construction in Progress Expenditures Incurred but Not yet Paid
IN8BIO, INC. (INAB) reported Construction in Progress Expenditures Incurred but Not yet Paid of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid · last filed 2024-11-12
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $0.00.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2023-12-31 was -$24.00K.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2023-09-30 was -$24.00K, a 112.50% decline year-over-year.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for the quarter ending 2022-12-31 was -$663.00K, a 1135.94% decline year-over-year.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for fiscal 2022 was $13.00K, a 86.17% decline from fiscal 2021.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for fiscal 2021 was $94.00K.
- IN8BIO, INC. construction in progress expenditures incurred but not yet paid for fiscal 2020 was $0.00.
| Period end | Construction in Progress Expenditures Incurred but Not yet Paid 3 month | Construction in Progress Expenditures Incurred but Not yet Paid 6 month | Construction in Progress Expenditures Incurred but Not yet Paid 9 month | Construction in Progress Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$48.00K derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-K · filed 2024-03-14 | |
| 2023-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $24.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $48.00K 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | -$663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$471.00K derived: sum of 2 quarters · filed 2024-03-14 | $13.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $676.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $484.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $94.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $30.00K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |